[{"Assets_0_Q2_USD":"3285594000.0","CIK":"875320","CommonStockSharesConverted_0_Q2_shares":"250769906.0","CommonStockSharesOutstanding_0_Q2_shares":"250769906.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.07","EarningsPerShareBasic_2_Q2_USD":"1.08","EarningsPerShareDiluted_1_Q2_USD":"0.07","EarningsPerShareDiluted_2_Q2_USD":"1.06","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","MinorityInterest_0_Q2_USD":"195958000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"447345000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":"17973000.0","NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":"265365000.0","NetIncomeLoss_1_Q2_USD":"17996000.0","NetIncomeLoss_2_Q2_USD":"265752000.0","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","ProfitLoss_1_Q2_USD":"31169000.0","ProfitLoss_2_Q2_USD":"280717000.0","RevenuesConverted_1_Q2_USD":"544135000.0","RevenuesConverted_2_Q2_USD":"1258853000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"1867231000.0","StockholdersEquity_0_Q2_USD":"1671273000.0","Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"251635000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"250199000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"247521000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"246782000.0","filed":"20170728","footnote":null,"form":"10-Q","fp":"Q2","fy":"2017.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20170630","qtrs":"0","uom":"USD"}]